Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
Nephros, Inc. (NEPH) to release Q4 and fiscal year financial results on March 7, 2024, followed by a conference call. The company offers filtration solutions for medical and commercial markets.
02/29/2024 - 04:30 PM
SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire Nephros, Inc.
Participants may dial into the call as follows:
Upon joining, please ask to be joined into the Nephros conference call.
An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page
Alternatively, a replay of the call may be accessed until March 14th, 2024 at 1 (877) 344-7529 or 1 (412) 317-0088 for international callers and entering replay access code: 3916556.
About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within medical and commercial markets, offering both proactive and emergency solutions for water management.
For more information about Nephros, please visit us at nephros.com
Investor Relations Contacts: ksmith@pcgadvisory.com
Robert Banks, CEOrobert.banks@nephros.com
When will Nephros release its fourth quarter and fiscal year financial results?
Nephros will release its financial results on Thursday, March 7, 2024, after market close.
What time will the conference call take place on March 7, 2024?
The conference call will be held at 4:30pm ET on the same day.
How can participants join the conference call?
Participants can dial 1 (844) 808-7106 for domestic access or 1 (412) 317-5285 for international access and ask to be joined into the Nephros conference call.
How long will the replay of the conference call be available?
The replay of the call will be accessible until March 14th, 2024, by dialing 1 (877) 344-7529 for domestic callers or 1 (412) 317-0088 for international callers and entering replay access code: 3916556.
NEPH Rankings
#361 Ranked by Stock Gains
NEPH Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Medical Specialties, Health Technology, Manufacturing, Surgical and Medical Instrument Manufacturing
About NEPH
nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil
